Ambulatory Infusion Centers Market Size (2024 - 2029)

The ambulatory infusion centers market is experiencing significant growth, driven by the increasing demand for infusion therapy outside traditional hospital settings. This expansion is supported by government initiatives aimed at enhancing healthcare accessibility and the rising prevalence of chronic diseases that require frequent infusion treatments. The market's growth is further fueled by the demand for cost-effective, patient-centric healthcare solutions, which prioritize minimally disruptive treatments. Despite these positive trends, challenges such as limited reimbursement coverage, slow digital transformation in some regions, and complex patient conditions may hinder the market's expansion.

Market Size of Ambulatory Infusion Centers Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Ambulatory Infusion Centers Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 46.09 Billion
Market Size (2029) USD 76.23 Billion
CAGR (2024 - 2029) 10.60 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Ambulatory Infusion Centers Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Ambulatory Infusion Centers Market Analysis

The Ambulatory Infusion Centers Market size is estimated at USD 46.09 billion in 2024, and is expected to reach USD 76.23 billion by 2029, growing at a CAGR of 10.60% during the forecast period (2024-2029).

Ambulatory infusion therapy is a facility that provides medical treatment outside the hospital. With the increase in demand for infusion therapy at alternate sites such as ambulatory infusion centers, there has been an upward trend in recent years for these centers. Also, the growing government initiatives to enhance healthcare facilities influence market growth. For instance, in March 2023, the US Department of Veterans Affairs (VA) launched an innovative program called "Close to Me Novel Infusion Care Delivery service," which aimed at reducing travel time for treatment to healthcare settings for Veterans. Through this program, twelve VA facilities across the country were selected for infusion treatment. This program covers eight CBOC care models, three home care models, and one mobile infusion unit site for infusion treatment at the initial stage.

Furthermore, the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, etc., fuels the growth of the ambulatory infusion centers market. This growing prevalence of chronic diseases requires more infusion treatment at home or in ambulatory infusion centers, which is one of the major factors responsible for the growth of the ambulatory infusion centers market. For instance, according to the British Heart Foundation, in 2023, around 620 million people were living with heart and circulatory diseases globally, and around 60 million people across the world develop a heart or circulatory disease every year.

In addition, rising demand for cost-effective and patient-centric healthcare solutions has also been fueling the growth of the ambulatory infusion centers market in recent years. There is a growing emphasis on patient-centered care, prioritizing treatments that can be delivered in the least disruptive manner possible in a cost-effective way, compelling healthcare providers to adopt this model. Hence, growing emphasis and demand for innovative solutions are fueling the growth of the ambulatory infusion centers market. For instance, Driscoll Children's Hospital in Texas, United States, adopted an innovative approach in 2022 for patient appointments on the same day for two or more specialties on the same day. Through this initiative, the project team set higher patient visit targets for each coming year, with an end goal to maintain or improve a rate of 8% from August 31, 2023, through August 31, 2025.

However, limited reimbursement coverage at specific sites, less digital transformation in developing countries, and more complex patient conditions restrain the market growth.

Ambulatory Infusion Centers Industry Segmentation

An ambulatory infusion center is a facility center that provides medical treatment outside of the hospital. With the emergence of infusion therapy, these infusion therapies are commonly available in many centers. These ambulatory infusion facility centers are specially designed to provide comfort and ease of relaxation. They provide a special space for the patient that makes their infusion session more effective. People who don’t respond to medicine well can get infusion therapy to recover quickly. Yet, they still avoid the total costs of being admitted to a hospital or nursing home.

The ambulatory infusion centers market is segmented into therapy type, application, site of care, and geography. The market is segmented by therapy type into Antibiotic, anti-fungal, anti-viral medication, blood product infusion, iron therapy, steroid infusion, immunoglobulin therapy, clotting factor replacement therapy, plasmapheresis, and Others. By application, the market is divided into oncology, neurology, gastrointestinal disorders, nutrition support, and others. By site of care, the market is segmented into hospitals, clinics, and Freestanding Infusion Centers. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report also offers the market size and forecasts for 15 countries across the region. For each segment, the market sizing and forecasts were made on the basis of value (USD).

By Therapy Type
Antibiotic, anti-fungal, anti-viral medication
Blood Product Infusion
Iron Therapy
Steroid Infusion
Immunoglobulin Therapy
Clotting Factor Replacement Therapy
Plasmapheresis
Other Therapy Types (Therapeutic Phlebotomy, etc.)
By Application
Oncology
Neurology
Gastro-intestinal Disorders
Nutrition Support
Other Applications (Rheumatology, Immunology, etc.)
By Site of Care
Hospitals
Clinics
Freestanding Infusion Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region Or Segment?
Customize Now

Ambulatory Infusion Centers Market Size Summary

The ambulatory infusion centers market is experiencing significant growth, driven by the increasing demand for infusion therapy outside traditional hospital settings. This trend is supported by government initiatives aimed at enhancing healthcare accessibility, such as the US Department of Veterans Affairs' program to reduce travel time for veterans seeking treatment. The rising prevalence of chronic diseases, including cancer and cardiovascular conditions, necessitates more infusion treatments, further propelling market expansion. Additionally, the shift towards cost-effective and patient-centric healthcare solutions is encouraging healthcare providers to adopt ambulatory infusion models, which prioritize less disruptive and more affordable treatment options.

The oncology segment within the ambulatory infusion centers market is particularly robust, fueled by the growing demand for cancer treatment and recent advancements in targeted infusion therapies. Technological innovations, such as smart pump integration and remote monitoring, are enhancing the efficacy and comfort of cancer treatments administered at these centers. North America is poised to dominate the market, supported by a high prevalence of cancer and cardiovascular diseases, along with strong government support and product approvals. The market is characterized by fragmentation, with numerous global and regional players, and recent strategic acquisitions and partnerships are expected to further shape the competitive landscape.

Explore More

Ambulatory Infusion Centers Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Government Initiatives to Enhance Healthcare Facilities

      2. 1.2.2 Increasing Prevalence of Chronic Diseases

      3. 1.2.3 Rising Demand for Cost-Effective and Patient-Centric Healthcare Solutions

    3. 1.3 Market Restraints

      1. 1.3.1 Limited Reimbursement Coverage at Certain Sites

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Therapy Type

      1. 2.1.1 Antibiotic, anti-fungal, anti-viral medication

      2. 2.1.2 Blood Product Infusion

      3. 2.1.3 Iron Therapy

      4. 2.1.4 Steroid Infusion

      5. 2.1.5 Immunoglobulin Therapy

      6. 2.1.6 Clotting Factor Replacement Therapy

      7. 2.1.7 Plasmapheresis

      8. 2.1.8 Other Therapy Types (Therapeutic Phlebotomy, etc.)

    2. 2.2 By Application

      1. 2.2.1 Oncology

      2. 2.2.2 Neurology

      3. 2.2.3 Gastro-intestinal Disorders

      4. 2.2.4 Nutrition Support

      5. 2.2.5 Other Applications (Rheumatology, Immunology, etc.)

    3. 2.3 By Site of Care

      1. 2.3.1 Hospitals

      2. 2.3.2 Clinics

      3. 2.3.3 Freestanding Infusion Centers

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Rest of the World

Ambulatory Infusion Centers Market Size FAQs

The Ambulatory Infusion Centers Market size is expected to reach USD 46.09 billion in 2024 and grow at a CAGR of 10.60% to reach USD 76.23 billion by 2029.

In 2024, the Ambulatory Infusion Centers Market size is expected to reach USD 46.09 billion.

Ambulatory Infusion Centers Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)